Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

New House Bill 1099 mandates comprehensive record-keeping for veterinary drug compounding

March 04, 2024 | House (Introduced), 2024 Bills, Maryland Legislation Bills Collections, Maryland



Black Friday Offer

Get Lifetime Access to Full Government Meeting Transcripts

Lifetime access to full videos, transcriptions, searches, and alerts at a county, city, state, and federal level.

$99/year $199 LIFETIME
Founder Member One-Time Payment

Full Video Access

Watch full, unedited government meeting videos

Unlimited Transcripts

Access and analyze unlimited searchable transcripts

Real-Time Alerts

Get real-time alerts on policies & leaders you track

AI-Generated Summaries

Read AI-generated summaries of meeting discussions

Unlimited Searches

Perform unlimited searches with no monthly limits

Claim Your Spot Now

Limited Spots Available • 30-day money-back guarantee

This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

New House Bill 1099 mandates comprehensive record-keeping for veterinary drug compounding
Maryland's House Bill 1099, introduced on March 4, 2024, aims to enhance the regulation of veterinary compounding practices, ensuring safer and more effective medication for animals. The bill outlines specific training requirements for veterinary technicians in compounding, emphasizing the importance of maintaining detailed records throughout the process.

Key provisions of House Bill 1099 include mandates for veterinary technicians to document the formula used, all active and inactive ingredients, equipment utilized, and the expiration dates of both the compounded drug and its ingredients. Additionally, the bill requires technicians to record the specific steps taken during compounding, as well as instructions for proper storage, handling, administration, and disposal of the compounded drugs. This comprehensive record-keeping is designed to improve accountability and traceability in veterinary practices.

The bill has sparked discussions among stakeholders, particularly regarding the balance between regulatory oversight and the operational flexibility of veterinary practices. Supporters argue that these measures are crucial for ensuring the safety and efficacy of compounded medications, which are often tailored to meet the specific needs of individual animals. However, some veterinary professionals express concerns about the potential administrative burden that such detailed documentation may impose on their practices.

The implications of House Bill 1099 extend beyond regulatory compliance; they touch on the broader issues of animal welfare and public health. By establishing clearer guidelines for compounding, the bill seeks to mitigate risks associated with improperly prepared medications, ultimately benefiting both pets and their owners.

As the legislative process unfolds, experts anticipate that the bill could lead to significant changes in how veterinary practices operate, potentially setting a precedent for similar regulations in other states. The outcome of House Bill 1099 will be closely monitored by veterinary professionals and animal advocates alike, as it could reshape the landscape of veterinary medicine in Maryland.

View Bill

This article is based on a bill currently being presented in the state government—explore the full text of the bill for a deeper understanding and compare it to the constitution

View Bill

Sponsors

Proudly supported by sponsors who keep Maryland articles free in 2025

Scribe from Workplace AI
Scribe from Workplace AI